- Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera The Wall Street Journal
- European markets negative; Novo Nordisk drops 3% after surprise bid for Metsera CNBC
- Novo Nordisk bid for obesity-focused biotech firm could gazump Pfizer offer The Guardian
- Novo Offers $6.5 Billion for Metsera to Challenge Pfizer Bloomberg.com
- Metsera says Novo Nordisk’s $9B buyout offer “superior”; Pfizer calls bid “illusory” (NVO:NYSE) Seeking Alpha
Source link
